Cardiovascular complications of diabetes mellitus: The Tissue Factor perspective

被引:27
作者
Bogdanov, Vladimir Y. [2 ]
Osterud, Bjarne [1 ]
机构
[1] Univ Tromso, Inst Med Biol, Dept Biochem, N-9037 Tromso, Norway
[2] Univ Cincinnati, Coll Med, Div Hematol Oncol, Cincinnati, OH USA
关键词
Tissue Factor; diabetes; cardiovascular complications; FACTOR PROCOAGULANT ACTIVITY; ENDOTHELIAL GROWTH-FACTOR; MONOCYTE-DERIVED MICROPARTICLES; ACUTE MYOCARDIAL-INFARCTION; FACTOR PATHWAY INHIBITOR; FACTOR EXPRESSION; WHOLE-BLOOD; P-SELECTIN; STIMULATED MONOCYTES; THROMBIN GENERATION;
D O I
10.1016/j.thromres.2009.06.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heightened activity of circulating Tissue Factor (TF) has been linked to a variety of macro-and microvascular cardiovascular complications commonly observed in diabetes mellitus. Systemic and localized vascular abnormalities comprise the most debilitating feature of diabetic pathophysiology. Blood monocytes are chronically activated in diabetes, and serve as the major source of bioactive intravascular TF. This review examines recent literature on this subject, with a special emphasis on the abnormal monocyte physiology in diabetes and the structural and functional diversity of circulating TF. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:112 / 118
页数:7
相关论文
共 88 条
[1]  
Aras Rohit, 2005, Rev Cardiovasc Med, V6, P84
[2]   Cardiovascular disease in patients with diabetic nephropathy [J].
Aso, Yoshimasa .
CURRENT MOLECULAR MEDICINE, 2008, 8 (06) :533-543
[3]   Tissue factor encryption [J].
Bach, RR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (03) :456-461
[4]   Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications [J].
Bajaj, M. S. ;
Ghosh, M. ;
Bajaj, S. P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (07) :1493-1499
[5]  
Bates DO, 2002, CANCER RES, V62, P4123
[6]   C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK 1/2 signaling dependent pathway [J].
Bello, Gaele ;
Cailotto, Frederic ;
Hanriot, Didier ;
Kolopp-Sarda, Marie-Nathalle ;
Latger-Cannard, Veronique ;
Hess, Ketsia ;
Zannad, Faiez ;
Lonorois, Dan ;
Ropars, Armelle .
ATHEROSCLEROSIS, 2008, 200 (02) :286-293
[7]   Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: Effects of insulin and glucose [J].
Boden, Guenther ;
Vaidyula, Vijender R. ;
Homko, Carol ;
Cheung, Peter ;
Rao, A. Koneti .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (11) :4352-4358
[8]   Identification and characterization of murine alternatively spliced tissue factor [J].
Bogdanov, VY ;
Kirk, RI ;
Miller, C ;
Hathcock, JJ ;
Vele, S ;
Gazdoiu, M ;
Nemerson, Y ;
Taubman, MB .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) :158-167
[9]   Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein [J].
Bogdanov, VY ;
Balasubramanian, V ;
Hathcock, J ;
Vele, O ;
Lieb, M ;
Nemerson, Y .
NATURE MEDICINE, 2003, 9 (04) :458-462
[10]   Generation of Tissue factor-rich microparticles in an ex vivo whole blood model [J].
Breimo, ES ;
Osterud, B .
BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (06) :399-405